Literature DB >> 2554792

Protease nexin I immunostaining in Alzheimer's disease.

D E Rosenblatt1, C Geula, M M Mesulam.   

Abstract

Immunohistochemical experiments showed that a small subset of neuritic plaques in brains affected by Alzheimer's disease stain positively with an antibody to the protease inhibitor protease nexin I. Nearly all plaques and tangles throughout the brain also showed a heightened avidity for a protease nexin I antibody-antigen aggregate, suggesting that plaques and tangles may have a particularly high density of protease nexin I-binding sites. These observations provide further evidence for a potential disruption of protein processing in the brains of patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554792     DOI: 10.1002/ana.410260507

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

4.  Effects of injected Alzheimer beta-amyloid cores in rat brain.

Authors:  S A Frautschy; A Baird; G M Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease.

Authors:  R N Kalaria; T Golde; S N Kroon; G Perry
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.

Authors:  Eleanor Drummond; Tomas Kavanagh; Geoffrey Pires; Mitchell Marta-Ariza; Evgeny Kanshin; Shruti Nayak; Arline Faustin; Valentin Berdah; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2022-04-13       Impact factor: 7.578

8.  Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.

Authors:  Henrik Karring; Ebbe Toftgaard Poulsen; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.